Literature DB >> 23354642

[Dupuytren disease].

Pablo Wagner1, Javier A Román, Jorge Vergara.   

Abstract

BACKGROUND: Dupuytren disease (DD) is a connective tissue disorder that consists in fibromatosis of the palmar and digital fascia (in form of nodules or flanges) that leads to the development of flexion contractures of the palm and fingers. The little and ring finger are particularly affected. The disease can limit hand function, reducing the quality of life. The disease can have a traumatic origin and is also associated with conditions such as diabetes mellitus, alcoholism, dyslipidemia, epilepsy and AIDS, among others. However, none of these conditions can fully explain the genesis of DD. A hereditary component is described in 40% of patients and is attributed to an autosomal dominant gene of variable penetrance, probably related to collagen synthesis. However there are also spontaneous and recessive inheritance cases. The diagnosis is clinical and based on physical examination. Treatment ranges from observation or use of injectable collagenase to the surgical option in cases with significant functional limitations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23354642     DOI: 10.4067/S0034-98872012000900013

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Dupuytren's disease: what dermatologists need to know.

Authors:  Camila Ribeiro Amadio; Barbara Machado Magalhães; Felipe Yazawa; Karine Simone
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

2.  Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease.

Authors:  Rujue Jin; Weigang Zhu; Jiajun Xu; Jianhui Gu; Aidong Deng
Journal:  Gene Ther       Date:  2022-03-28       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.